Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Vomiting 2Testicular Neoplasms 1Neoplasms, Germ Cell and Embryonal 1Melanoma 1Carcinoma, Renal Cell 1

Interventions

Etoposide 30Carboplatin 30Cisplatin 23Ifosfamide 22Filgrastim 22Paclitaxel 18Peripheral Blood Stem Cell Transplantation 16Bleomycin 13Cyclophosphamide 11Radiotherapy 8Thiotepa 7Magnetic Resonance Spectroscopy 6Gemcitabine 6pegfilgrastim 5Therapeutics 5Polymerase Chain Reaction 5Melphalan 5Granulocyte Colony-Stimulating Factor 5Flow Cytometry 5Busulfan 5etoposide phosphate 4Temozolomide 4Psychiatric Rehabilitation 4Oxaliplatin 4Dexamethasone 4sargramostim 3Vinblastine 3Taxes 3Surveys and Questionnaires 3Methylprednisolone 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Testicular Neoplasms × fosaprepitant × Genitourinary × Clear all
NCT01736917 2016-05-25

Fosaprepitant + 5HT3 Receptor Antagonists + Dexamethasone in Germ Cell Tumors

Hoosier Cancer Research Network

Phase 2 Completed
65 enrolled 14 charts
Genitourinary

Neoplasms, Germ Cell and Embryonal, Testicular Neoplasms, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡